12/21
Headlines

NASDAQ:CBPO

Trader’s Watch List: Whiting Petroleum Corp. (NYSE:WLL), Hewlett-Packard Company (NYSE:HPQ), MagnaChip Semiconductor Corporation (NYSE:MX), China Biologic Products, Inc. (NASDAQ:CBPO), LKQ Corp. (NASDAQ:LKQ)

Colin Pettis02 mins

An issue of Whiting Petroleum Corp (NYSE:WLL) debt fell 3% as a percentage of its face value during trading on Tuesday after Global Hunter Securities downgraded the stock from a buy rating to an accumulate rating, StockRatingsNetwork.com reports. The high-yield debt issue has a 5% coupon and is set to mature on March 15, 2019….

Read More

Active Stocks: Knowles Corporation (NYSE:KN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), China Biologic Products, Inc. (NASDAQ:CBPO), Air Transport Services (NASDAQ:ATSG), Full Circle Capital (NASDAQ:FULL)

John Bellich03 mins

On Nov 21, Knowles Corporation (NYSE:KN), announced its Taiwan facility is celebrating 40 years of dedication to leading acoustic technologies and superior customer service and will host a technical workshop to help mark the occasion. Knowles Corporation (NYSE:KN) belongs to Technology sector. Its net profit margin is -3.80% and weekly performance is 8.26%. On last…

Read More

Stocks to Watch : Zogenix, Inc. (NASDAQ:ZGNX), Morgan Stanley (NYSE:MS), China Biologic Products, Inc. (NASDAQ:CBPO), Resonant Inc. (NASDAQ:RESN), Arbor Realty Trust Inc. (NYSE:ABR)

Chris Lewis03 mins

Zogenix Inc. (NASDAQ: ZGNX) has submitted its supplemental new drug application (sNDA) with the U.S. Food and Drug Administration, we have seen some analyst commentary that is worth noting. Oppenheimer’s Akiva Felt and Angad Verma have issued their report. The official rating remains as Outperform, but what stands out here is that the $2.50 price…

Read More

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

Mark Doerr03 mins

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was…

Read More

Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)

Kevin Long02 mins

Vital Therapies currently has a Zacks Rank #3 (Hold). Vital Therapies Inc (NASDAQ:VTL) stock performance was -5.83% in last session and finished the day at $30.52. Traded volume was 94.00K shares in the last session and the average volume of the stock remained 96.31K shares. China Biologic Products (CBPO) shares fell in late trading after…

Read More
Gilead Sciences GILD NASDAQ:GILD

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton03 mins

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc…

Read More